Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

RUNX3 Promoter Region is Specifically Methylated in Poorly-differentiated Colorectal Cancer

YASUHIRO IMAMURA, KENJI HIBI, MASAHIKO KOIKE, MICHITAKA FUJIWARA, YASUHIRO KODERA, KATSUKI ITO and AKIMASA NAKAO
Anticancer Research July 2005, 25 (4) 2627-2630;
YASUHIRO IMAMURA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENJI HIBI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: khibi@med.nagoya-u.ac.jp
MASAHIKO KOIKE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHITAKA FUJIWARA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUHIRO KODERA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KATSUKI ITO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIMASA NAKAO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 25 no. 4 2627-2630
PubMed 
16080503

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 23, 2005
  • Accepted April 21, 2005
  • Published online July 1, 2005.

Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. YASUHIRO IMAMURA*,
  2. KENJI HIBI*,
  3. MASAHIKO KOIKE,
  4. MICHITAKA FUJIWARA,
  5. YASUHIRO KODERA,
  6. KATSUKI ITO and
  7. AKIMASA NAKAO
  1. Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan
  1. Correspondence to: Kenji Hibi, Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa-ku, Nagoya 466-8560, Japan. Tel: +81-52-744-2245, Fax: +81-52-744-2255, e-mail: khibi{at}med.nagoya-u.ac.jp

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 25 (4)
Anticancer Research
Vol. 25, Issue 4
1 Jul 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
RUNX3 Promoter Region is Specifically Methylated in Poorly-differentiated Colorectal Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 19 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
RUNX3 Promoter Region is Specifically Methylated in Poorly-differentiated Colorectal Cancer
YASUHIRO IMAMURA, KENJI HIBI, MASAHIKO KOIKE, MICHITAKA FUJIWARA, YASUHIRO KODERA, KATSUKI ITO, AKIMASA NAKAO
Anticancer Research Jul 2005, 25 (4) 2627-2630;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
RUNX3 Promoter Region is Specifically Methylated in Poorly-differentiated Colorectal Cancer
YASUHIRO IMAMURA, KENJI HIBI, MASAHIKO KOIKE, MICHITAKA FUJIWARA, YASUHIRO KODERA, KATSUKI ITO, AKIMASA NAKAO
Anticancer Research Jul 2005, 25 (4) 2627-2630;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Demethylation of RUNX3 by Vincristine in Colorectal Adenocarcinoma Cells
  • Google Scholar

More in this TOC Section

  • Ubiquitin-proteasome Pathway-linked Gene Signatures as Prognostic Indicators in Prostate Cancer
  • SH003 Inhibits Proliferation and Induces Apoptosis in Colon Cancer Through the RTK-STAT3 Pathway
  • Advantages and Disadvantages of Drug Combination Treatment: Riluzole, Metformin and Dexamethasone Effect on Glioblastoma Cell
Show more Experimental Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire